Höffken H, Rummel H H, Heinrich D, Leppien G
Geburtshilfe Frauenheilkd. 1981 Mar;41(3):184-7. doi: 10.1055/s-2008-1037351.
In a preliminary study the new "Histocan"-needle was tested in respect of its diagnostic value in patients with palpatory findings suspicious for recurrent cancer in the pelvis and in patients with breast tumours. Initially there were some difficulties in handling the biopsy needle. Furthermore we saw some haematomas after breast biopsy, which could be avoided, however, by compression of the biopsy wound. From the morphological point of view the fine structures of tissue specimen were without the gross needle-conditioned artifacts and in some respect could be interpreted better than in Silverman-biopsies. Statistical data can only be given after finishing our cooperative studies.
在一项初步研究中，对新型“组织穿刺活检针”在骨盆触诊发现疑似复发性癌症的患者以及乳腺肿瘤患者中的诊断价值进行了测试。最初，活检针的操作存在一些困难。此外，我们发现乳腺活检后出现了一些血肿，不过，通过压迫活检伤口可以避免这种情况。从形态学角度来看，组织标本的细微结构没有粗大的针造成的伪像，在某些方面比西尔弗曼活检的标本能得到更好的解读。只有在完成我们的合作研究后才能给出统计数据。
